Evolus (EOLS) Change in Inventory (2019 - 2026)
Evolus (EOLS) posted Change in Inventory of -$6.4 million for Q1 2026, down 36.9% on a QoQ basis from -$4.7 million in Q4 2025, and down 57.48% year-over-year from -$15.0 million in Q1 2025.
Evolus (EOLS) Change in Inventory (2019 - 2026) Analysis & Trends
Evolus' Change in Inventory history runs 8 years deep, the most recent figure standing at -$6.4 million for Q1 2026.
- Quarterly Change in Inventory fell 57.48% year-over-year to -$6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.8 million (up 541.34% YoY) and the FY2025 annual result came in at $11.1 million, up 442.07% from the prior year.
- Change in Inventory was -$6.4 million for Q1 2026 at Evolus, down from -$4.7 million in the prior quarter.
- Across five years, Change in Inventory topped out at $11.5 million in Q3 2025 and bottomed at -$6.4 million in Q1 2026.
- A 5-year average of $469941.2 and a median of -$848000.0 in 2023 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 678.59% in 2025, while the deepest fall reached 375.89% in 2025.
- Evolus' Change in Inventory stood at -$4.6 million in 2022, then slipped by 5.48% to -$4.8 million in 2023, then surged by 79.8% to -$979000.0 in 2024, then plunged by 375.89% to -$4.7 million in 2025, then tumbled by 36.9% to -$6.4 million in 2026.
- Business Quant data shows EOLS's Change in Inventory at -$6.4 million in Q1 2026, -$4.7 million in Q4 2025, and $11.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.38 Mn |
| Mar 31, 2026 | -6.38 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Dec 31, 2025 | -4.66 Mn |
| Sep 30, 2025 | 11.49 Mn |
| Sep 30, 2025 | 11.49 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Jun 30, 2025 | 8.34 Mn |
| Mar 31, 2025 | -4.05 Mn |
| Mar 31, 2025 | -4.05 Mn |
| Dec 31, 2024 | -979,000.00 |
| Dec 31, 2024 | -979,000.00 |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Mar 31, 2024 | -5.31 Mn |
| Dec 31, 2023 | -4.85 Mn |
| Dec 31, 2023 | -4.85 Mn |